Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.

myTempleHealth
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH
Back To Doctor Search

Michiko Taniguchi, PhD

Michiko Taniguchi

Specialties

Pathology

Loading ...
About Me
Offices
Publications
Ratings & Reviews
About Me
Offices

Office Locations

Temple University Hospital - Main Campus

3401 N. Broad Street

Philadelphia, PA 19140

Phone: 800-836-7536

Publications
Publications

1. Ciurea SO, Al Malki MM, Kongtim P, Zou J, Aung FM, Rondon G, Chen J, Taniguchi M, Otoukesh S, Nademanee A, Forman SJ, Champlin RE, Gendzekhadze K, and Cao K. Treatment of Allosensitized Patients Receiving Allogeneic Transplantation." Blood Adv. 2021 (in press)

2. Taniguchi M, Rebellato LM, Briley KP, Haisch CE, Bolin P, Banuelos N, Hopfield J, Terasaki PI, Everly MJ. Risk Stratification of HLA-class II Donor Specific Antibody Positive Patients by IgG Subclasses. Clin Transpl. 2015;31:293-301.

3. Taniguchi M. Antibodies against “DANGER” in the dynamic of post-transplant circulation. Clin Transpl. 2014

4. Ohe H, Uchida Y, Yoshizawa A, Hirano H, Taniguchi M, Maruya E, Yurugi K, Hishida R, Maekawa T, Uemoto S, Terasaki PI. Association of anti-human leukocyte antigen and anti-angiotensin II type 1 receptor antibodies with liver allograft fibrosis after immunosuppression withdrawal. Transplantation. 2014; 98: 1105-11.

5. Taniguchi M, Rebellato LM, Cai J, Hopfield J, Briley KP, Haisch CE, Catrou PG, Bolin P, Parker K, Kendrick WT, Kendrick SA, Harland RC, Terasaki PI. Higher risk of kidney graft failure in the presence

6. Waki K, Sugawara Y, Mizuta K, Taniguchi M, Ozawa M, Hirata M, Nozawa M, Kaneko J, Takahashi K, Kadowaki T, Terasaki PI, Kokudo N. Predicting operational tolerance in pediatric living-donor liver transplantation by absence of HLA antibodies. Transplantation. 2013;95:177-83.

7. Kaneku H, O'Leary JG, Taniguchi M, Susskind BM, Terasaki PI, Klintmalm GB. Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation. Liver Transpl. 2012;18:984-92.

8. Taniguchi M. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry. Clin Transpl. 2012:41-65.

9. Ravindranath MH, Taniguchi M, Chen CW, Ozawa M, Kaneku H, El-Awar N, Cai J, Terasaki PI. HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies. Mol Immunol. 2010;47:1121-31.

10. Taniguchi M, Kawabata M. KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection. Immunogenetics. 2009;61:717-30.

Ratings & Reviews

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient Comments

Loading ...